Past Program Awardees
On September 13, 2004, the National Cancer Institute (NCI) announced a major commitment to develop and apply nanotechnology to cancer research. To carry out this initiative, the NCI, formed the NCI Alliance for Nanotechnology in Cancer, a comprehensive, integrated initiative encompassing researchers, clinicians, and public and private organizations, to develop and translate cancer-related nanotechnology research into clinical practice.
Initial focus for this research was in the areas of:
- Molecular imaging and early detection
- In vivo nanotechnology imaging systems
- Reporters of efficacy
- Multifunctional therapeutics
- Prevention and control
- Research enablers
Follow the links below to view the past program awardees:
Centers of Cancer Nanotechnology Excellence (2005-2010)
Carolina Center of Cancer Nanotechnology Excellence
University of North Carolina
Principal Investigator: Rudolph Juliano, Ph.D.
Center for Cancer Nanotechnology Excellence Focused on Therapy Response
Principal Investigator: Sanjiv Sam Gambhir, M.D., Ph.D.
Center of Nanotechnology for Treatment, Understanding, and Monitoring of Cancer (NANO-TUMOR)
University of California, San Diego
Principal Investigator: Sadik Esener, Ph.D.
Emory-Georgia Tech Nanotechnology Center for Personalized and Predictive Oncology
Emory University and Georgia Institute of Technology
Principal Investigators: Shuming Nie, Ph.D.
MIT-Harvard Center of Cancer Nanotechnology Excellence
MIT and Harvard University, Massachusetts General Hospital
Principal Investigators: Robert Langer, Ph.D., and Ralph Weissleder, M.D., Ph.D.
Nanomaterials for Cancer Diagnostics and Therapeutics
Principal Investigator: Chad Mirkin, Ph.D.
Nanosystems Biology Cancer Center (NSBCC)
California Institute of Technology
Principal Investigator: James Heath, Ph.D.
The Siteman Center of Cancer Nanotechnology Excellence
Principal Investigator: Samuel Wickline, M.D.
Cancer Nanotechnology Platform Partnerships (2005-2010)
Detecting Cancer Early with Targeted Nano-probes for Vascular Signatures
University of California
Principal Investigator: Douglas Hanahan, Ph.D.
DNA-linked Dendrimer Nanoparticle Systems for Cancer Diagnosis and Treatment
University of Michigan
Principal Investigator: James Baker Jr., M.D.
Hybrid Nanoparticles in Imaging and Therapy of Prostate Cancer
University of Missouri
Principal Investigator: Kattesh Katti, Ph.D.
Integrated System for Cancer Biomarker Detection
Massachusetts Institute of Technology
Principal Investigator: Scott Manalis, Ph.D.
Metallofullerene Nanoplatform for Imaging and Treating Infiltrative Tumor
Virginia Commonwealth University
Principal Investigator: Panos Fatouros, Ph.D.
Multifunctional Nanoparticles in Diagnosis and Therapy of Pancreatic Cancer
State University of New York
Principal Investigator: Paras Prasad, Ph.D.
Nanotechnology Platform for Pediatric Brain Cancer Imaging and Therapy
University of Washington
Principal Investigator: Miqin Zhang, Ph.D.
Nanotechnology Platform for Targeting Solid Tumors
The Sidney Kimmel Cancer Center
Principal Investigator: Jan Schnitzer, M.D.
Nanotherapeutic Strategy for Multidrug Resistant Tumors
Principal Investigator: Mansoor Amiji, Ph.D.
Near-Infrared Fluorescence Nanoparticles for Targeted Optical Imaging
The University of Texas M. D. Anderson Cancer Center
Principal Investigator: Chun Li, Ph.D.
Novel Cancer Nanotechnology Platforms for Photodynamic Therapy and Imaging
Roswell Park Cancer Institute
Principal Investigator: Ravindra K. Pandey, Ph.D.
Photodestruction of Ovarian Cancer: ErbB3 Targeted Aptamer-Nanoparticle Conjugate
Massachusetts General Hospital
Principal Investigator: Tayyaba Hasan, Ph.D.
Multidisciplinary Research Training and Team Development (2005-2010)
Multidisciplinary Research Training and Team Development Fellowship Awards were granted to the following postdoctoral trainees:
Design of Affinity Capture Agents for Akt1 Using in situ Click Chemistry, California Institute of Technology, Pasadena, CA
Trainee: Steven W. Millward, Ph.D.
Geldanamycin-Mediated Uptake of Nanoparticle Probes, Purdue University, West Lafayette, Indiana
Trainee: Giselle M. Knudsen, Ph.D.
Liposomal Delivery of High LET Emitters to Cell Nuclei, Johns Hopkins University, Baltimore, Maryland
Trainee: Yah-El Har-El, Ph.D.
Nanolabels of Active Proteases for Cancer Detection, University of California, San Francisco, California
Trainee: Mark D. Lim, Ph.D.
Nanoparticle-Bioconjugates as Cancer-Treating Agents, Texas A&M University, College Station, Texas
Trainee: Sofi Bin-Salamon, Ph.D.
Nanoprobes and Integrated Nanodevices for Cancer Detection and Treatment, University of Colorado Health Services, Superior, CO
Trainee: Wounjhang Park, Ph.D.
Nanoscale Mechanisms of Hsp90 and Its Co-chaperones, Yale University, New Haven, Connecticut
Trainee: Ivo P. Doudevski, Ph.D.
Short-Interfering RNA-Gold Nanoparticle Bioconjugates: A New Cancer Therapy, Northwestern University, Evanston, Illinois
Trainee: Adam B. Braunschweig, Ph.D.
Single Walled Carbon Nanotube Based Tumor Vaccines, Memorial Sloan-Kettering Institute for Cancer Research, New York, New York
Trainee: Rena J. May, Ph.D.
Targeted Delivery Via Protein-Carbohydrate Interactions, Liquidia, Inc., Research Triangle Park, North Carolina
Trainee: Ashley L. Galloway, Ph.D.
Targeted Photoactivated Nanopartcicles for the Treatment of Ovarian Cancer, Massachusetts General Hospital, Boston, MA
Trainee: Daniel Neuman, Ph.D.
NCI-NSF Training Grants were awarded in 2005 to establish training programs for U.S. science and engineering doctoral students through the Integrative Graduate Education and Research Traineeship Program (IGERT). The awarded programs were:
Building Leadership for the Nanotechnology Workforce of Tomorrow, University of Washington
Principal Investigator: Marjorie Olmstead, Ph.D.
Integrative Nanoscience and Microsystems, University of New Mexico
Principal Investigator: Diana Huffaker, Ph.D.
Nanomedical Science and Technology, Northeastern University
Principal Investigator: Srinivas Sridhar, Ph.D.
NanoPharmaceutical Engineering and Science, Rutgers University
Principal Investigator: Fernando Muzzio, Ph.D.